Exogenous insulin is the essential treatment for patients with type 1 diabetes and for patients with insulin-requiring type 2 diabetes, underscoring the critical role of insulin and its analogs in managing the disease. The gene discussed is INS; the disease is type 1 diabetes mellitus.